KLK3 and benign prostatic hyperplasia: Increased total prostate-specific antigen (tPSA) is the most frequently used laboratorial biomarker to identify prostatic changes21, although tPSA has only a moderate sensitivity to discriminate between PCa and BPH as well as for predicting increased risk of metastasis22.